Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in <named-content content-type="genus-species">Streptococcus pneumoniae</named-content>

ABSTRACT β-Lactam antibiotics are the drugs of choice to treat pneumococcal infections. The spread of β-lactam-resistant pneumococci is a major concern in choosing an effective therapy for patients. Systematically tracking β-lactam resistance could benefit disease surveillance. Here we developed a c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuan Li, Benjamin J. Metcalf, Sopio Chochua, Zhongya Li, Robert E. Gertz, Hollis Walker, Paulina A. Hawkins, Theresa Tran, Cynthia G. Whitney, Lesley McGee, Bernard W. Beall
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2016
Materias:
Acceso en línea:https://doaj.org/article/f6e11664c4cf436ba1df123fd5c0ad22
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f6e11664c4cf436ba1df123fd5c0ad22
record_format dspace
spelling oai:doaj.org-article:f6e11664c4cf436ba1df123fd5c0ad222021-11-15T15:50:16ZPenicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in <named-content content-type="genus-species">Streptococcus pneumoniae</named-content>10.1128/mBio.00756-162150-7511https://doaj.org/article/f6e11664c4cf436ba1df123fd5c0ad222016-07-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00756-16https://doaj.org/toc/2150-7511ABSTRACT β-Lactam antibiotics are the drugs of choice to treat pneumococcal infections. The spread of β-lactam-resistant pneumococci is a major concern in choosing an effective therapy for patients. Systematically tracking β-lactam resistance could benefit disease surveillance. Here we developed a classification system in which a pneumococcal isolate is assigned to a “PBP type” based on sequence signatures in the transpeptidase domains (TPDs) of the three critical penicillin-binding proteins (PBPs), PBP1a, PBP2b, and PBP2x. We identified 307 unique PBP types from 2,528 invasive pneumococcal isolates, which had known MICs to six β-lactams based on broth microdilution. We found that increased β-lactam MICs strongly correlated with PBP types containing divergent TPD sequences. The PBP type explained 94 to 99% of variation in MICs both before and after accounting for genomic backgrounds defined by multilocus sequence typing, indicating that genomic backgrounds made little independent contribution to β-lactam MICs at the population level. We further developed and evaluated predictive models of MICs based on PBP type. Compared to microdilution MICs, MICs predicted by PBP type showed essential agreement (MICs agree within 1 dilution) of >98%, category agreement (interpretive results agree) of >94%, a major discrepancy (sensitive isolate predicted as resistant) rate of <3%, and a very major discrepancy (resistant isolate predicted as sensitive) rate of <2% for all six β-lactams. Thus, the PBP transpeptidase signatures are robust indicators of MICs to different β-lactam antibiotics in clinical pneumococcal isolates and serve as an accurate alternative to phenotypic susceptibility testing. IMPORTANCE The human pathogen Streptococcus pneumoniae is a leading cause of morbidity and mortality worldwide. β-Lactam antibiotics such as penicillin and ceftriaxone are the drugs of choice to treat pneumococcal infections. Some pneumococcal strains have developed β-lactam resistance through altering their penicillin-binding proteins (PBPs) and have become a major concern in choosing effective patient therapy. To systematically track and predict β-lactam resistance, we obtained the sequence signatures of PBPs from a large collection of clinical pneumococcal isolates using whole-genome sequencing data and found that these “PBP types” were predictive of resistance levels. Our findings can benefit the current era of strain surveillance when whole-genome sequencing data often lacks detailed resistance information. Using PBP positions that we found are always substituted within highly resistant strains may lead to further refinements. Sequence-based predictions are accurate and may lead to the ability to extract critical resistance information from nonculturable clinical specimens.Yuan LiBenjamin J. MetcalfSopio ChochuaZhongya LiRobert E. GertzHollis WalkerPaulina A. HawkinsTheresa TranCynthia G. WhitneyLesley McGeeBernard W. BeallAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 7, Iss 3 (2016)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Yuan Li
Benjamin J. Metcalf
Sopio Chochua
Zhongya Li
Robert E. Gertz
Hollis Walker
Paulina A. Hawkins
Theresa Tran
Cynthia G. Whitney
Lesley McGee
Bernard W. Beall
Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in <named-content content-type="genus-species">Streptococcus pneumoniae</named-content>
description ABSTRACT β-Lactam antibiotics are the drugs of choice to treat pneumococcal infections. The spread of β-lactam-resistant pneumococci is a major concern in choosing an effective therapy for patients. Systematically tracking β-lactam resistance could benefit disease surveillance. Here we developed a classification system in which a pneumococcal isolate is assigned to a “PBP type” based on sequence signatures in the transpeptidase domains (TPDs) of the three critical penicillin-binding proteins (PBPs), PBP1a, PBP2b, and PBP2x. We identified 307 unique PBP types from 2,528 invasive pneumococcal isolates, which had known MICs to six β-lactams based on broth microdilution. We found that increased β-lactam MICs strongly correlated with PBP types containing divergent TPD sequences. The PBP type explained 94 to 99% of variation in MICs both before and after accounting for genomic backgrounds defined by multilocus sequence typing, indicating that genomic backgrounds made little independent contribution to β-lactam MICs at the population level. We further developed and evaluated predictive models of MICs based on PBP type. Compared to microdilution MICs, MICs predicted by PBP type showed essential agreement (MICs agree within 1 dilution) of >98%, category agreement (interpretive results agree) of >94%, a major discrepancy (sensitive isolate predicted as resistant) rate of <3%, and a very major discrepancy (resistant isolate predicted as sensitive) rate of <2% for all six β-lactams. Thus, the PBP transpeptidase signatures are robust indicators of MICs to different β-lactam antibiotics in clinical pneumococcal isolates and serve as an accurate alternative to phenotypic susceptibility testing. IMPORTANCE The human pathogen Streptococcus pneumoniae is a leading cause of morbidity and mortality worldwide. β-Lactam antibiotics such as penicillin and ceftriaxone are the drugs of choice to treat pneumococcal infections. Some pneumococcal strains have developed β-lactam resistance through altering their penicillin-binding proteins (PBPs) and have become a major concern in choosing effective patient therapy. To systematically track and predict β-lactam resistance, we obtained the sequence signatures of PBPs from a large collection of clinical pneumococcal isolates using whole-genome sequencing data and found that these “PBP types” were predictive of resistance levels. Our findings can benefit the current era of strain surveillance when whole-genome sequencing data often lacks detailed resistance information. Using PBP positions that we found are always substituted within highly resistant strains may lead to further refinements. Sequence-based predictions are accurate and may lead to the ability to extract critical resistance information from nonculturable clinical specimens.
format article
author Yuan Li
Benjamin J. Metcalf
Sopio Chochua
Zhongya Li
Robert E. Gertz
Hollis Walker
Paulina A. Hawkins
Theresa Tran
Cynthia G. Whitney
Lesley McGee
Bernard W. Beall
author_facet Yuan Li
Benjamin J. Metcalf
Sopio Chochua
Zhongya Li
Robert E. Gertz
Hollis Walker
Paulina A. Hawkins
Theresa Tran
Cynthia G. Whitney
Lesley McGee
Bernard W. Beall
author_sort Yuan Li
title Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in <named-content content-type="genus-species">Streptococcus pneumoniae</named-content>
title_short Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in <named-content content-type="genus-species">Streptococcus pneumoniae</named-content>
title_full Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in <named-content content-type="genus-species">Streptococcus pneumoniae</named-content>
title_fullStr Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in <named-content content-type="genus-species">Streptococcus pneumoniae</named-content>
title_full_unstemmed Penicillin-Binding Protein Transpeptidase Signatures for Tracking and Predicting β-Lactam Resistance Levels in <named-content content-type="genus-species">Streptococcus pneumoniae</named-content>
title_sort penicillin-binding protein transpeptidase signatures for tracking and predicting β-lactam resistance levels in <named-content content-type="genus-species">streptococcus pneumoniae</named-content>
publisher American Society for Microbiology
publishDate 2016
url https://doaj.org/article/f6e11664c4cf436ba1df123fd5c0ad22
work_keys_str_mv AT yuanli penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
AT benjaminjmetcalf penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
AT sopiochochua penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
AT zhongyali penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
AT robertegertz penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
AT holliswalker penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
AT paulinaahawkins penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
AT theresatran penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
AT cynthiagwhitney penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
AT lesleymcgee penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
AT bernardwbeall penicillinbindingproteintranspeptidasesignaturesfortrackingandpredictingblactamresistancelevelsinnamedcontentcontenttypegenusspeciesstreptococcuspneumoniaenamedcontent
_version_ 1718427436649021440